Nicofuranose

This classification denotes a vasodilating agent and anti-lipidemic agent with the molecular formula C30H24N4O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GF99P6327K, chemically known as 1,3,4,6-tetra-o-nicotinoyl-d-fructofuranose but generally known as nicofuranose, which bears US NIH Compound Identifier 25495. European Medicines Agency schedules Nicofuranose in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09237MIG. The term NICOFURANOSE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules nicofuranose in its Anatomical Therapeutic Chemical (ATC) Classification. NICOFURANOSE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicofuranose under HS 29400000 and SITC 51692. As of Q4 2014, NICOFURANOSE remains the US FDA Preferred Term for this commodity. Nicofuranose bears US NLM identifiers UMLS ID C0354652 and NCI Concept Code C83921. SMILES: O1C(O)(C(OC(=O)c2cccnc2)C(OC(=O)c2cccnc2)C1COC(=O)c1cccnc1)COC(=O)c1cccnc1.